Tay-Sachs Disease:
Genetic Disorder - autosomal recessive, meaning both parents have to be carrier of the disease. Mutation still around because the heterozygous enjoys decreased risk towards tuberculosis
Causes Gangliosidosis, which is a group of 3 lysosomal storage disease. It is caused by the inability to catabolize GM2 gangliosides. Degradation of GM2 requires 3 polypeptides encoded by 3 separate loci.
Phenotypic effects of mutations in these genes are similar, because they all result in the accumulation of GM2 gangliosides. The molecular enzyme defect however varies in the 3.
Tay-Sachs is the most common GM2 gangliosidosis. It results from a mutation in the alpha - subunit locus chromosome 15 and causes severe hexosaminidase A deficiency.��
Absence of hexosaminidase A in virtually all tissues including leukocytes and plasmacytes. This therefore causes accumulation of GM2 gangliosides in those tissues(heart, spleen, liver?)
Involvement of neurons in the CNS and ANS and retina are dominant clinical picture
Histologically� neurons are ballooned with cytoplasmic� vacuoles, which constitutes lysosome filled with gangliosides.
Positive Stains for fat (Oil Red O, Sudan Black B)
Cytoplasmic inclusions (most prominent being whorled configuration within lysosomes. Composed of onion skin layers of membranes
Progressive destruction of neurons, proliferation of microglia and accumulation of lipids in phagocytes within the CNS
Similar process in cerebellum as well as in basal ganglia, brain stem and ANS
Ganglion cells in retina are similarly swollen with GM2 gangliosides, particular at margins of macula (cherry-red-spot) appears presenting accentuation of the normal color of the macular choriod contrasted with pallor produced by swollen ganglion cells. This finding is characteristic for storage disorder affecting neurons.
Most common Tay-Sachs allele is a 4base insertion in the hexosaminidase A gene. This leads to mutation that causes a formation of a stop codon downstream
Symptoms:
Symptoms usually start at age 6months
Motor and mental deterioration(incoordination, mental obtundation, muscular flaccidy)�
Blindness
Deafness
Increased dementia
Difficulty swallowing
Muscle Atrophy, which leads to paralysis
Death usually within the first 2-3 years
Diagnosis:
Genetic Testing can be done to determine the probability of producing an offspring with that disorder
Treatment:
Unfortunately none as of now, but research is being conducting to treat patients with the disorder.
Personal MedBox
Index
Hosted by www.Geocities.ws

1